Cloning and expression of MPT83 gene from Mycobacterium tuberculosis in E. coli BL21 as vaccine candidate of tuberculosis: A preliminary study

WHO. BCG – The Current Vaccine for Tuberculosis. Initiative for vaccine research. World Heath Organization; 2012. Available at: <http://www.who.int>. WHO Parida, 2010, Novel tuberculosis vaccines on the horizon, Curr Opin Immunol, 22, 374, 10.1016/j.coi.2010.04.006 Rodrigues, 1993, Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis, Int J Epidemiol, 22, 1154, 10.1093/ije/22.6.1154 Jouanguy, 1996, Interferon gamma reseptor deficiency in an infant with fatal bacille Calmette-Guerin Infection, N Engl J Med, 335, 1956, 10.1056/NEJM199612263352604 Chu, 2011, Expression, purification, and characterization of protective MPT64 antigen protein and identification of its multimers isolated from nontoxic Mycobacterium tuberculosis H37Ra, Biotechnol Appl Biochem, 58, 185, 10.1002/bab.26 Yang, 2014, Mycobacterium tuberculosis Rv1096 protein: gene cloning, protein expression, and peptidoglycan deacetylase activity, BMC Microbiol, 14, 1 Khademi, 2017, Mycobacterium tuberculosis HspX/EsxS fusion protein: gene cloning, protein expression, and purification in Escherichia coli, Rep. Biochem. Mol. Biol., 6, 15 Kao, 2012, The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice, PLoS One, 7, e34991, 10.1371/journal.pone.0034991 Sambrook, 1989 Ahmad, 1999, WD repeats of the p48 subunit of chicken chromatin assembly factor-1 required for in vitro interaction with chicken histone deacetylase-2, J Biol Chem, 274, 16646, 10.1074/jbc.274.23.16646